Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

CoreAge Rx vs Medivive

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Medivive a 63. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

CoreAge Rx

#1 · Grade A+ · Best Value

Est. first month

$99/mo

Save ~89% vs brand-name
Get this deal Full CoreAge Rx review →
VS

Medivive

#344 · Grade C · Watch List

Est. first month

From $162/mo (compounded)

Save ~88% vs brand-name
Get this deal Full Medivive review →

The verdict

Better value: CoreAge Rx

CoreAge Rx takes it on Value Score, 93 to 63 an est. $99/mo first month, with no teaser step-up baked in. Medivive isn't out of it: A Spanish-speaking patient who wants one provider across weight, hormones and general care.

CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxMedivive
Value Score93 (A+)63 (C)
Est. first month$99/moFrom $162/mo (compounded)
Save vs brand-name~89%~88%
Semaglutide$99/moNot disclosed
Tirzepatide$149/moNot disclosed
Both moleculesYesNo
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
79
CoreAge Rx: 88. Medivive: 79.
98
No Teaser-Rate Bait
60
CoreAge Rx: 98. Medivive: 60.
98
Nationwide Availability
45
CoreAge Rx: 98. Medivive: 45.
95
Both Molecules
45
CoreAge Rx: 95. Medivive: 45.
95
Easy Cancellation
58
CoreAge Rx: 95. Medivive: 58.
84
Reputation
60
CoreAge Rx: 84. Medivive: 60.

CoreAge Rx

The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.

Why it's a deal

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation — no lock-in

The fine print

  • Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Medivive

Medivive is a bilingual English and Spanish telehealth service covering all 50 states, with prescribing handled by the named TeleEval Medical Group and compounded GLP-1s filled by a 503A pharmacy.

Why it's a deal

  • Names the prescribing medical group — TeleEval Medical Group — rather than referring vaguely to a clinician network
  • Care is delivered in English and Spanish, which few programs tracked here offer
  • Covers all 50 states with a clinician licensed in your own state making the prescribing decision
  • No membership fee, and the site states outright that treatment is never guaranteed

The fine print

  • No price is published anywhere — the figure here was disclosed only after completing an AI-led intake
  • The 503A pharmacy that fills the protocol is not named
  • The individual service states are not listed even though all 50 are claimed
  • Weight sits alongside hormone and general care, so the GLP-1 program is one line among several
Get the CoreAge Rx deal Get the Medivive deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Medivive.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.